WADA and the 2026 Annual Report: The Testing Curve Is Slowing, and Trust Is Stretching Thin

There is a small quiet gap in the figures that I spent an entire evening re-reading, and it is not in the headline. The World Anti-Doping Agency's 2026 annual report opens with a number that sounds encouraging: 297,965 samples collected in 2026, up roughly 9,100 from the 288,865 of 2026. But when I place the two figures on a longer timeline, from 2026 to 2026, a very different story emerges than the title suggests.

I am someone who reads movement before results. With a scoreboard, I always want to know the rhythm behind it — which team accelerated at which minute, which player dropped intensity just before the goal. WADA's dataset works the same way. It does not tell me who is doping. It tells me how fast the system is operating, and how that speed is changing.

And that speed is slowing.

From 2026 to 2026, total tests rose 12.5%. From 2026 to 2026, growth was only 3.2%. This is not a uniform curve — it climbs steeply early, then flattens. A testing system is still expanding, but its rate of expansion has fallen to less than a quarter of what it was just one year earlier. That is the truth beneath the headline "WADA increases sample testing."

Context: this is not a swimming-technique story

Before going further, I must be clear about my standing when reading this document. I work as a multi-sport commentator, and the sport I follow most deeply is swimming. But this report is not an analysis of stroke, turn, or race craft. It is a governance and statistical document on anti-doping, cross-sport in scope. If I forced it into a swimming-technique story, I would be lying. And I hold one rule: I may not say everything, but I will not say what is false.

That means most technical dimensions of swimming — starts, underwater work, lane efficiency — cannot be applied here. I mark them "insufficient information, cannot assess." The only "technical" layer available is the process of testing itself: how samples are collected, how organizations are audited, how money is allocated. It sounds dry, but it is precisely where every swimmer in the world lives.

Why I care about a governance report: swimming is one of the most test-intensive sports. Every athlete, every event, every out-of-competition check depends on a national anti-doping body with a budget. When that budget tightens, the first thing to vanish is not medals — it is the quiet six a.m. sample collection at meets nobody broadcasts.

Core insight: four pillars of the report

Pillar one — testing volume is decelerating

The total of 297,965 samples in 2026 is a large number. But to read it correctly, I must place it next to the growth rate. When a system adds 9,100 samples while infrastructure stays flat, where does the increase come from? Two possibilities, and the data cannot separate them: either it is reaching a new population, or testing the same population more densely.

The striking part is that this growth curve flattens precisely in the period when financial strain surfaces at the end of the report. I read two separate data clusters and placed them side by side, and they align suspiciously well. When the expansion rate of a program falls to roughly a quarter within a single year, that is rarely a strategic choice. It is usually the sign of a resource ceiling.

Pillar two — the positive-test rate is flat

For three straight years, the Adverse Analytical Finding (AAF) rate barely moved: 0.77% (2026), 0.80% (2026), 0.78% (2026). The band is under 0.03 percentage points.

For a data analyst, this is the most robust finding in the entire report. Volume rises, but the detection rate holds steady. That means total positives rise proportionally too — not because more athletes are doping, but simply because more samples are being tested.

I once mispronounced N'Golo Kante's name three times on live air, and the cost of misreading a single name taught me that every conclusion must come from a system, not from a memorized moment. The 0.78% figure is the same. Read alone, it is meaningless. Read across three years, it becomes a stable baseline I can use as a reference point for every report that follows.

And such a stable baseline admits two explanations that the current data cannot separate: either doping prevalence is genuinely stable, or smarter targeting is reaching a population of comparable positivity. The report does not tell me which.

Pillar three — compliance improves, but on one axis it deteriorates

This is the part I most want readers to notice, because it is a paradox. The report finds the average number of non-conformities per organization fell from 25.5 to 20. The author calls it "a win for WADA." But this figure is drawn from only nine compliance audits. Nine. With a sample that small, an improvement cannot justify any system-wide conclusion.

And when I dissect the structure of the non-conformities, the picture changes color. Testing-related issues account for 45% of all findings, up 11% year-over-year, with 23% rated critical. In other words: overall it sounds better, but precisely on the most important axis — sample collection — things are getting worse.

There are discoveries that do not come from luck, but from being willing to read the movements the crowd overlooks. An average of 20 looks better than 25.5. But decomposed, I see a structure rotting at its base.

Pillar four — money, and a political fault line

WADA reports a budget shortfall of $8.3 million against plan. The United States has not paid $3.8 million, and Russia owes $3.9 million. These are the two largest gaps, and both are political rather than accounting matters.

The paradox: the report still records a net surplus of $1.2 million. A system can be $8.3 million short of plan and still post a $1.2 million surplus only through aggressive cost control or deferred spending. And in an organization whose core spending is testing, cutting spending almost certainly reaches the quality and frequency of sample collection.

One more pillar worth noting: a strategic pivot

WADA states it is shifting from predominantly traditional athlete drug testing toward investigations and prevention. The accompanying figures are concrete: more than 250 investigation operations, 88 laboratories dismantled, more than 90 tons of materials seized.

This is a valuable directional signal. It shows the organization is choosing to invest in high-concentration strikes rather than spreading resources evenly across sports. For swimming — a heavily tested sport that is rarely at the center of large doping networks — this pivot may mean routine testing thins out in favor of targeted campaigns.

I always ask one question of any system: if variable X changes, how does the system respond? If funding from major nations keeps falling, variable X is the budget. And the rational response of a cash-strapped organization is to concentrate on high-yield operations, leaving behind the steady, unglamorous programs.

A fixed milestone: the 2027 Code

The most important time anchor in the report is not a statistic but a date. The 2027 edition of the World Anti-Doping Code and Standards was adopted in Busan, South Korea, and takes effect January 1, 2027.

It is a milestone with a concrete date, and for any federation planning ahead, that is high planning value. But it also creates a compliance-gap window stretching from now to early 2027. Within that window, old-rule behavior may persist while the pressure to transition is not yet strong enough to force change.

Alongside this, WADA and its Athlete Council ran an athlete-centered consultation with more than 600 athletes and commissions from over 60 countries and over 70 sports. Formally, this is a carefully designed legitimacy-building step. But the report offers no measure showing athlete input actually changed the substance of the Code. Voice being heard is one thing. Voice being written into the text is another.

The contrarian angle: the headline says one thing, the data another

This is the section I want to spend the most time on, because it is where my analytical instinct is tested.

The report's headline is about increasing sample testing. But the data show growth decelerating from 12.5% to 3.2%. The author calls the compliance improvement "a win for WADA." But the data show that on the testing axis — the most important axis — non-conformities rose 11%. A system described as expanding is running an $8.3 million budget shortfall while its two largest contributors are in arrears.

These three contradictions are not mine. They sit inside the same document. What I have learned over years of writing about sport is this: when a report's headline is more optimistic than its body, trust the body. The headline sells the news. The body defends the truth.

I asked myself: am I being too suspicious? I tried to construct the most conventional, reasonable reading. That reading is: testing rises, positivity holds steady, compliance improves, a new Code is adopted — a healthy picture. That reading has its own logic, and I respect it. But it overlooks three details in the deeper layers: decelerating growth, a deteriorating testing axis, and threatened funding.

Data does not judge, but it points me to the questions others forget. And the question I consider most important here is: when an organization says it is doing more while its own data show it slowing down, what is actually happening inside?

One more possibility deserves the table: most testing non-conformities may concentrate in low-resource nations. This is inference, not data stated in the report, so I mark it low confidence. But if true, it means emerging swimming federations — already thin on anti-doping infrastructure — will be the first to lose out.

One thing I cannot ignore: the 2026 annual report compiles figures for 2026 and 2026. That suggests two possibilities — either a one-year publication-lag convention, or inconsistent data labeling. Either way, when citing, I will use the percentages themselves rather than the headline number. A careful analyst reads the footnotes before the conclusion.

I recall the pandemic period. When world football froze and stadiums emptied, I spent five months logging defensive situations without crowds, only to find that high-pressing teams lost about 15% effectiveness without crowd noise. That number taught me that environmental context can change the meaning of an entire tactical system. For WADA, the environmental context is money. And money is shifting.

What to watch

A few signals I will track over the next 12 to 18 months. First, the testing growth rate in the next report. If it stalls or turns negative, that is not a coincidence — it is capacity erosion. Second, the AAF rate. If it breaks above roughly 0.85%, I must revisit the stable-baseline assumption, because prevalence or targeting may be shifting. Third, the share of testing non-conformities. If it keeps exceeding 45%, the problem is no longer isolated. Fourth, the contribution status of the United States and Russia. Fifth, national-agency readiness for the 2027 Code.

I rate the overall risk in this picture as medium to high. Not because of any single factor — each is manageable alone. But because of three pressures at once: decelerating growth, rising non-conformities, and funding shortfalls from the largest contributors. These three forces resonate into pressure on the very axis anti-doping must protect: the ability to guarantee every athlete is tested fairly.

One countervailing bright spot I do not want to skip: the $1.2 million net surplus and clear growth in investigations. These are genuine counterweights, not empty reassurance. But a surplus achieved by cutting spending at the testing stage is not good news. It is a short-term loan, and its interest will be paid in athlete trust.

A thought to leave behind

Swimming — and all sport — operates on an assumption fans rarely see: that whoever stands on the starting block tomorrow has been tested as fairly as the person beside them. That assumption does not exist naturally. It is built with budgets, with national agencies, and with six a.m. sample collections nobody broadcasts.

What I see in WADA's 2026 annual report is not a collapsing system. It is a system adding 9,100 samples while its rate of acceleration falls to a quarter, and precisely at the most important stage its non-conformities rise 11%. Such a system still runs. But it runs under strain.

For a swimmer, the question is not whether WADA increases testing. The question is whether her country's anti-doping agency has the resources to knock on the door on some March morning. When a system says it is expanding while its own numbers say it is slowing, trust in that system begins to rest on something very fragile: the ability to tell apart a communications message from the real state of the lane.

I still keep the habit of reading any organization's data table before believing its conclusion. Not because I distrust people. Because I trust process. And if the process needs more investment precisely when budgets are tightening, what I want to know is who will be accountable for the samples never collected.

No headline answers that question. Only the next season, and the next report, can.